Fingerprint
Dive into the research topics of 'Response to mepolizumab treatment is sustained across 4-weekly dosing periods'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Response to mepolizumab treatment is sustained across 4-weekly dosing periods
Ian D. Pavord, Eugene R. Bleecker, Roland Buhl, Pascal Chanez, Elisabeth H. Bel, Peter Howarth, Daniel J. Bratton, Frank C. Albers, Steven Yancey
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations